Compassionate use of ruxolitinib in patients with SARS‐Cov‐2 infection not on mechanical ventilation: Short‐term effects on inflammation and ventilation

Compassionate use of ruxolitinib in patients with SARS‐Cov‐2 infection not on mechanical ventilation: Short‐term effects on inflammation and ventilation

Abstract Ruxolitinib is an anti‐inflammatory drug that inhibits the Janus kinase‐signal transducer (JAK‐STAT) pathway on the surface of immune cells. The potential targeting of this pathway using JAK inhibitors is a promising approach in patients affected by coronavirus disease 2019 (COVID‐19). Ruxo...

Full description

Saved in:
Bibliographic Details
Main Authors: Andrea Mortara (Author), Simone Mazzetti (Author), Davide Margonato (Author), Pietro Delfino (Author), Chiara Bersano (Author), Francesco Catagnano (Author), Marinella Lauriola (Author), Paolo Grosso (Author), Gianluca Perseghin (Author), Giovanbattista Ippoliti (Author)
Format: Book
Published: Wiley, 2021-05-01T00:00:00Z.
Subjects:
article
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available

Similar Items